financetom
Market
financetom
/
Market
/
Dow Settles At New Record High: Investor Sentiment Declines But Fear Index Remains In 'Greed' Zone
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Dow Settles At New Record High: Investor Sentiment Declines But Fear Index Remains In 'Greed' Zone
Sep 23, 2024 2:11 AM

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the “Greed” zone on Friday.

U.S. stocks settled higher on Friday, with the Dow Jones index settling at a record high during the session. The US Federal Reserve, on Wednesday, slashed interest rates by 50 basis points Wednesday at its September Federal Open Market Committee meeting, lowering the federal funds rate to a range of 4.75% to 5%.

All three major indices recorded weekly gains, with the S&P 500 gaining around 1.4% and adding more than 19% in 2024. The Dow gained around 1.6% last week, while the tech-heavy Nasdaq jumped around 1.5% during the week.

FedEx Corporation ( FDX ) shares dipped over 15% on Monday after the company reported worse-than-expected first-quarter financial results and cut FY25 guidance.

Most sectors on the S&P 500 closed on a negative note, with industrials, materials and information technology stocks recording the biggest losses on Friday. However, utilities and communication services stocks bucked the overall market trend, closing the session higher.

The Dow Jones closed higher by around 38 points to 42,063.36 on Friday. The S&P 500 fell 0.19% to 5,702.55, while the Nasdaq Composite dipped 0.36% to 17,948.32 during Friday's session.

Investors are awaiting earnings results from AAR Corp ( AIR ). and Red Cat Holdings, Inc. ( RCAT ) today.

What is CNN Business Fear & Greed Index?

At a current reading of 62.9, the index remained in the “Greed” zone on Friday, versus a prior reading of 65.1.

The Fear & Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.

Read Next:

Jim Cramer: Viking Has ‘Many Ships Coming In’

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Financial
Sector Update: Financial
Nov 4, 2024
03:29 PM EDT, 11/01/2024 (MT Newswires) -- Financial stocks advanced in late Friday afternoon trading, with the NYSE Financial Index up 0.4% and the Financial Select Sector SPDR Fund (XLF) rising 0.6%. The Philadelphia Housing Index eased 0.1%, and the Real Estate Select Sector SPDR Fund (XLRE) declined 0.6%. Bitcoin (BTC-USD) dropped 1.8% to $69,050, and the yield for 10-year...
Sector Update: Energy
Sector Update: Energy
Nov 4, 2024
03:20 PM EDT, 11/01/2024 (MT Newswires) -- Energy stocks were lower late Friday afternoon, with the NYSE Energy Sector Index decreasing 0.5% and the Energy Select Sector SPDR Fund (XLE) shedding 0.6%. The Philadelphia Oil Service Sector index was posting a 0.8% decline, and the Dow Jones US Utilities index fell 1.9%. Front-month West Texas Intermediate crude oil rose 0.4%...
US STOCKS-Wall St rallies as Amazon's gains offset weak job growth
US STOCKS-Wall St rallies as Amazon's gains offset weak job growth
Nov 4, 2024
* Amazon.com ( AMZN ) surges as retail strength boosts profit * US job growth slows sharply in October * Consumer discretionary index up 2.3% * Indexes up: Dow 0.74%, S&P 500 0.52%, Nasdaq 0.81% (Updates as of 2:15 p.m. EDT (1815 GMT)) By Abigail Summerville Nov 1 (Reuters) - Wall Street's major indexes climbed on Friday, rebounding from the...
Top Midday Decliners
Top Midday Decliners
Nov 4, 2024
02:16 PM EDT, 11/01/2024 (MT Newswires) -- ESSA Pharma ( EPIX ) said late Thursday it decided to terminate the phase 2 trial evaluating the combination of masofaniten and enzalutamide in patients with metastatic castration-resistant prostate cancer compared with enzalutamide alone. Shares slumped 71%, with intraday trading volume at over 27.6 million compared with a daily average of about 59,000....
Copyright 2023-2026 - www.financetom.com All Rights Reserved